Pubdate: Sat, 04 Nov 2000 Source: National Journal (DC) Copyright: 2000 National Journal Group Inc. Contact: 1501 M St., NW #300, Washington, DC 20005 Fax: (202) 833-8069 Website: http://nationaljournal.com/njweekly/ Section: Social Issues Bookmark: ONDCP Media Campaign http://www.mapinc.org/campaign.htm FROM THE FRYING PAN INTO THE FIRE On the desk of Alan Levitt, the man who heads the national advertising campaign to get kids to stop using drugs, sits a glass bowl with a plastic fish inside. Levitt likes to hold it up for visitors in order to make a point: He feels like the fish in the bowl, constantly on display, always under someone's watchful eye. And he's right. Since the Office of National Drug Control Policy began its unprecedented $1 billion, five-year, anti-drug campaign 30 months ago, Congress and the press have been relentless in their scrutiny of the program's progress. Now, halfway through its course, the ad campaign may be showing some early signs of success. Yet most of the attention has been on the campaign's blunders. While struggling to get its anti-drug ads off the ground, the drug policy office has been forced to defend itself against attacks on several fronts. Media outlets accused the office of censorship and tampering with network TV scripts; Congress is investigating fraud and overbilling among the office's contractors. At times it seemed as if the office spent the first half of the campaign fighting a lot more than youth drug use. The campaign had its origins in the famous egg-and-frying-pan ad of the late 1980s and early 1990s: "This is your brain-splat-this is your brain on drugs." That ad was created by the Partnership for a Drug-Free America, a private, nonprofit, nonpartisan coalition of professionals from the communications industry. Major advertising agencies donated ads for free, and the media ran them as public service announcements. In 1989 and 1990, the partnership's combined media exposure reached the equivalent of $1 million in advertising spending per day. The ads seemed to be helping. By 1992, adolescent drug use was at a low point. Between 1985 and 1992, monthly use of illicit drugs among adolescents 12 to 17 years of age had dropped from 3.2 million children to 1.3 million, according to the annual National Household Survey on Drug Abuse conducted by the Health and Human Services Department. But a year later, things started to change. In 1994, the number went back up to 2.1 million. The partnership's ads were receiving less and less exposure because the national media, mainly network television, was splintering. By 1997, the trends were not good. Drug use, particularly for marijuana, was up among adolescents. The combination of negative trends and the changing media market led Jim Burke, the chairman of the partnership, and retired Army Gen. Barry McCaffrey, the director of the Office of National Drug Control Policy, to press President Clinton and Congress for government money to pay for placements of the anti-drug ads. With encouragement from Clinton, Congress appropriated $1 billion to the drug policy office for an anti-drug media campaign aimed specifically at youth. The money, however, came with several stipulations. Every media outlet that accepted paid advertising from the campaign had to match that air time, or advertising space, with an equal amount of unpaid public service announcements, or with other programs or activities related to reducing youth substance abuse. Passage of the law set in motion the largest government-sponsored ad campaign ever, designed to include television, radio, print, billboards, and interactive media. The government campaign still uses ads from the private partnership, but shapes their tone and content. In the past, the partnership had a reputation of using scare tactics (as well as inaccurate information) to emphasize the negative consequences of drugs. But the drug policy office decided that it wanted the ads to stress not only the bad consequences of drug use, but also the need for responsible parenting and the positive aspects of a drug-free lifestyle. It established a panel of behavioral scientists to review the partnership ads to ensure that they were in line with the campaign's message. Making all the campaign's components come together has not been easy, however. Although the partnership likes the increased exposure of its more widely placed ads, its creative players have felt stifled by the government's oversight. Before the government's involvement, 100 percent of the direction for the ads came from a creative review panel at the partnership, said Shawn Clarken, the partnership's creative director. "When the [government] got involved and had control of the purse strings, the situation changed dramatically," Clarken said. "Now their social scientists do a final review of the ads. Frankly, it's been a source of creative tension." Levitt, federal director of the National Youth Anti-Drug Media Campaign, insists that the drug policy office's scientific approach and review are absolutely necessary. "These are taxpayers' funds," he says. "We need to make sure that we're hitting our targets." Bickering with the partnership has perhaps been the least of the drug policy office's problems. Its biggest blow came in January, when Salon.com broke a story exposing the office's practice of awarding millions of dollars in financial credit to TV networks, including NBC, ABC, CBS, and Fox, whose prime-time programming complied with the media campaign's anti-drug message. If an episode of a TV series contained an anti-drug message, the network would get credit for that, and this credit would reduce the number of free public service announcements it was obligated to run. The network could then sell the time that might have gone for public service announcements for paid advertising. Episodes of Beverly Hills 90210 and Chicago Hope were among those that received the office's stamp of approval. Soon after, Salon.com ran stories highlighting similar deals that the drug policy office had with print publications, such as U.S. News & World Report, Seventeen, and USA Weekend. After the first story broke, members of Congress and the media criticized the practices on two grounds-that they were a scam of the original intent, and worse, that they raised the specter of the government determining what people read and viewers watched. Both Congress and the media demanded that the drug office change its policy-which it has, sort of. Today, the drug office insists that at the time the stories broke, two fairly innocent policies were unfairly jumbled together in the public's mind. One policy, the office says, involved only consulting. Levitt says that TV and film writers would come to the office for advice on how to accurately depict drug use in their scripts. Levitt and his colleagues would field their queries and offer advice, he says, often without knowing what show or movie was being discussed. At the same time, he and others in the office were also reviewing scripts and articles with anti-drug messages submitted by networks and publications that were seeking public service announcement credit. Levitt insists that the two procedures never overlapped and that the office staff never knew that some of the episodes and stories they were reviewing had not yet been aired or published. Since then, however, it has altered the guidelines it provides to media outlets that are seeking credit. Any program or article submitted must have already been printed or broadcast. Publications can only seek credit for features, not news stories or editorials. Moreover, Ogilvy and Mather, the advertising agency that has been hired to purchase media airtime and space for the campaign, is now in charge of reviewing scripts and articles. Levitt and others at the drug office continue to field phone calls only from writers seeking technical advice. Still, despite the revised policies, many policy experts and First Amendment advocates have ongoing concerns about the drug policy office's relationship to the media. "The only reason that people haven't become more outraged about this form of censorship is because it's difficult to understand," says Graham Boyd, director of the Drug Policy Litigation Project at the American Civil Liberties Union. "The bottom line is that TV networks and publications make a significant amount of money by conforming their messages to what the government wants to hear. I can't imagine the public would stand for that if the messages involved women's reproductive rights or other controversial issues." Just last month, the anti-drug campaign found itself again on the defensive. Rep. John L. Mica, R-Fla., chairman of the House Government Reform Committee's Subcommittee on Criminal Justice, Drug Policy, and Human Resources, called an Oct. 14 hearing to examine possible mismanagement, overbilling, and contract fraud within the media campaign. It was the campaign's seventh congressional hearing. For hours, Mica and Republican members of the subcommittee grilled Levitt and other officials about allegations that Ogilvy and Mather had inflated its labor costs and overcharged the government millions of dollars. The drug office maintains that it is not at fault, and pointed out that it was one of its own officials who brought the questionable billings to light and withheld $15 million to Ogilvy and Mather and other contractors. Still, Congress ordered the Government Accounting Office to investigate further. Despite these setbacks, the media campaign's leadership is confident it will succeed. Levitt points proudly to the office's outreach to the entertainment industry, its placement of more than 300,000 public service announcements, and its targeting of ads at ethnic communities as positive signs of the campaign's progress. But the campaign's true measure of success-lowering youth drug use-has yet to be determined. The National Institute on Drug Abuse is conducting an evaluation of the campaign, with the help of Westat, a survey research corporation. The first results are scheduled for this spring. In the meantime, drug policy officials are sleeping easier, knowing that the rate of overall drug use among youth appears to be going down. Between 1997 and 1999, according to the household survey, the percent of youths using drugs dropped from 11.4 percent to 9 percent. - --- MAP posted-by: Eric Ernst